Eslicarbazepine acetate
- Level
- Commodity
- Parent
- 51141500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51141592This classification denotes an anticonvulsant agent C17H16N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier BEA68ZVB2K, chemically known as (10s)-5-carbamoyl-10,11-dihydro-5h-dibenzo(b,f)azepin-10-yl acetate, but more generally known as eslicarbazepine acetate, which bears US NIH Compound Identifier 179344. European Medicines Agency schedules Eslicarbazepine acetate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB30424. Most nations, for tariff and trade purposes, schedule eslicarbazepine acetate under HS 29339930 and SITC 51577. As of Q4 2014, ESLICARBAZEPINE ACETATE remains US FDA's Preferred Term for this commodity. Eslicarbazepine acetate bears US NLM identifiers UMLS ID C2725262 and NCI Concept Code C83697. SMILES: CC(=O)O[C@H]1CC2CCCCC2N(C3C1CCCC3)C(=O)N.
Same parent
Under 51141500 · 80Activities that produce or sell this
KBLI · 8Inherited from family 51140000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.